4mha
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
+ | |||
==Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC1817== | ==Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC1817== | ||
<StructureSection load='4mha' size='340' side='right' caption='[[4mha]], [[Resolution|resolution]] 2.59Å' scene=''> | <StructureSection load='4mha' size='340' side='right' caption='[[4mha]], [[Resolution|resolution]] 2.59Å' scene=''> | ||
Line 6: | Line 7: | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4m3q|4m3q]], [[3tcp|3tcp]], [[2brb|2brb]], [[3bpr|3bpr]], [[2poc|2poc]], [[4mh7|4mh7]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4m3q|4m3q]], [[3tcp|3tcp]], [[2brb|2brb]], [[3bpr|3bpr]], [[2poc|2poc]], [[4mh7|4mh7]]</td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Receptor_protein-tyrosine_kinase Receptor protein-tyrosine kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 2.7.10.1] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Receptor_protein-tyrosine_kinase Receptor protein-tyrosine kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 2.7.10.1] </span></td></tr> | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4mha FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4mha OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4mha RCSB], [http://www.ebi.ac.uk/pdbsum/4mha PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4mha FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4mha OCA], [http://pdbe.org/4mha PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4mha RCSB], [http://www.ebi.ac.uk/pdbsum/4mha PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4mha ProSAT]</span></td></tr> |
</table> | </table> | ||
== Disease == | == Disease == | ||
Line 20: | Line 21: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
+ | <div class="pdbe-citations 4mha" style="background-color:#fffaf0;"></div> | ||
==See Also== | ==See Also== |
Revision as of 16:41, 11 August 2016
Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC1817
|
Categories: Receptor protein-tyrosine kinase | Branchford, B R | Deryckere, D | Dipaola, J A | Earp, H S | Frye, S | Graham, D K | Hunter, D | Janzen, W P | Kireev, D B | Lee, M | Machius, M | Mciver, A | Miley, D B.M | Norris-Drouin, J | Sather, S | Stashko, M A | Stewart, W M | Wang, X | Zhang, W | Zhou, Y | Acute lymphoblastic leukemia | Rational structure-based drug design | Transferase-transferase inhibitor complex | Tyrosine kinase